20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Glaukos Corp (GKOS) operates in the MEDICAL DEVICES industry and is headquartered in Aliso Viejo, United States with about 1,094 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2025-12-31, GKOS reported $507M in revenue and ($188M) in net income.
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
Interactive charts & full statements → Open the GKOS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $614M | $507M | $383M | $315M | $283M | $294M | $225M | $237M | $181M | $159M | $114M | $72M | $46M | $21M | $2M |
| Gross Profit | $485M | $393M | $289M | $239M | $214M | $227M | $133M | $198M | $156M | $138M | $98M | $59M | $34M | $18M | $1M |
| Gross Margin % | 79.0% | 77.5% | 75.5% | 76.0% | 75.6% | 77.3% | 59.2% | 83.7% | 86.2% | 86.8% | 85.9% | 81.9% | 75.0% | 87.9% | 31.9% |
| Operating Income (EBIT) | ($80M) | ($87M) | ($122M) | ($129M) | ($82M) | ($33M) | ($124M) | ($50M) | ($13M) | ($2M) | $4M | ($10M) | ($13M) | ($14M) | ($22M) |
| Operating Margin % | -13.0% | -17.1% | -31.9% | -40.9% | -29.1% | -11.2% | -54.9% | -21.2% | -7.2% | -1.4% | 3.7% | -14.4% | -28.9% | -67.8% | -909.8% |
| Net Income | ($188M) | ($188M) | ($146M) | ($135M) | ($99M) | ($50M) | ($120M) | $15M | ($13M) | $0M | $5M | ($37M) | ($12M) | ($13M) | ($19M) |
| Net Margin % | -30.6% | -37.0% | -38.2% | -42.8% | -35.1% | -16.9% | -53.5% | 6.5% | -7.1% | -0.1% | 4.0% | -51.9% | -26.6% | -60.3% | -795.8% |
| EBITDA | ($152M) | ($146M) | ($96M) | ($82M) | ($49M) | ($1M) | ($84M) | ($38M) | ($7M) | $5M | $9M | ($33M) | ($9M) | ($13M) | ($21M) |
| Earnings Per Share (EPS) | $-3.25 | $-3.28 | $-2.77 | $-2.78 | $-2.09 | $-1.07 | $-2.70 | $0.37 | $-0.37 | $-0.00 | $0.12 | $-2.13 | $-0.49 | $-0.51 | $-9.73 |
| Shares Outstanding (M) | 58M | 57M | 53M | 48M | 47M | 46M | 44M | 41M | 35M | 34M | 36M | 17M | 25M | — | 2M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $186M | $151M | $143M | $134M | $124M | $107M | $105M | $97M |
| Gross Profit | $152M | $117M | $111M | $105M | $97M | $82M | $77M | $74M |
| Gross Margin % | 81.7% | 77.9% | 77.8% | 78.4% | 78.3% | 77.2% | 72.9% | 76.6% |
| Operating Income (EBIT) | ($17M) | ($20M) | ($27M) | ($16M) | ($23M) | ($21M) | ($29M) | ($25M) |
| Operating Margin % | -9.3% | -13.2% | -18.9% | -12.3% | -18.3% | -19.4% | -27.2% | -25.5% |
| Net Income | ($18M) | ($20M) | ($134M) | ($16M) | ($20M) | ($18M) | ($34M) | ($21M) |
| Net Margin % | -9.9% | -13.1% | -93.4% | -12.2% | -15.8% | -17.0% | -31.8% | -22.1% |
| EBITDA | ($17M) | ($5M) | ($125M) | ($5M) | ($9M) | ($7M) | ($22M) | ($10M) |
| Earnings Per Share (EPS) | $-0.31 | $-0.34 | $-2.32 | $-0.28 | $-0.34 | $-0.32 | $-0.60 | $-0.39 |
| Shares Outstanding (M) | 58M | 58M | 58M | 57M | 57M | 57M | 56M | 55M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($1M) | ($15M) | ($61M) | ($58M) | ($33M) | $25M | ($23M) | $0M | $19M | $26M | $12M | ($2M) | ($7M) | ($13M) | ($20M) |
| Capital Expenditures (CapEx) | $12M | $8M | $6M | $20M | $30M | $48M | $7M | $5M | $10M | $6M | $6M | $1M | $1M | $1M | $1M |
| Free Cash Flow (FCF) | ($12M) | ($23M) | ($68M) | ($78M) | ($63M) | ($23M) | ($30M) | ($5M) | $9M | $19M | $6M | ($3M) | ($8M) | ($14M) | ($21M) |
| FCF Margin % | -1.9% | -4.5% | -17.6% | -24.8% | -22.4% | -7.8% | -13.3% | -2.1% | 4.7% | 12.0% | 5.3% | -4.3% | -17.5% | -67.6% | -864.1% |
| Dividends Paid | — | — | — | — | $6M | $27M | $263M | $13M | — | $0M | $0M | $0M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $15M | ($13M) | $7M | ($10M) | $7M | ($19M) | $1M | ($10M) |
| Capital Expenditures (CapEx) | $3M | $4M | $3M | $2M | $1M | $2M | $2M | $1M |
| Free Cash Flow (FCF) | $12M | ($16M) | $4M | ($12M) | $6M | ($20M) | ($1M) | ($11M) |
| FCF Margin % | 6.5% | -10.9% | 2.8% | -8.8% | 4.7% | -19.2% | -1.2% | -11.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $921M | $893M | $975M | $940M | $1.1B | $1.1B | $1.0B | $818M | $207M | $166M | $134M | $117M | $26M | $31M | $5M |
| Cash & Cash Equivalents | $114M | $91M | $170M | $93M | $120M | $101M | $97M | $62M | $30M | $25M | $6M | $22M | $2M | $7M | $2M |
| Total Liabilities | $238M | $237M | $208M | $479M | $544M | $542M | $338M | $145M | $33M | $28M | $17M | $21M | $187M | $180M | $14M |
| Total Debt (Short + Long-Term) | $0M | $0M | $2M | $285M | $282M | $281M | $191M | $2M | $0M | $0M | $0M | $10M | $19M | $18M | $0M |
| Total Shareholders' Equity | $682M | $656M | $767M | $462M | $530M | $587M | $667M | $673M | $174M | $138M | $117M | $95M | ($151M) | ($141M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GKOS viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms